Globalization Act’s Drug Safety Provisions Look Harmful For Industry
This article was originally published in The Tan Sheet
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys
You may also be interested in...
An inter-agency group will advise President Obama "as soon as possible" on improving food safety enforcement across federal agencies
FDA would have been able to act earlier to limit the impact of contaminated peanut products if food firms were required to report all positive tests for contaminants, according to an agency executive
At an upcoming hearing, House Energy and Commerce Committee leaders will question executives from labs that tested ingredients at the peanut processing facility linked to widespread recalls due to salmonella contamination